Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Enterprise Value (2018 - 2025)

Historic Enterprise Value for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.3 million.

  • Dna X's Enterprise Value rose 5228.48% to -$4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 5228.48%. This contributed to the annual value of -$8.0 million for FY2024, which is 1619.76% up from last year.
  • Per Dna X's latest filing, its Enterprise Value stood at -$4.3 million for Q3 2025, which was up 5228.48% from -$5.4 million recorded in Q2 2025.
  • Dna X's Enterprise Value's 5-year high stood at -$4.3 million during Q3 2025, with a 5-year trough of -$18.2 million in Q2 2022.
  • For the 5-year period, Dna X's Enterprise Value averaged around -$10.0 million, with its median value being -$9.6 million (2024).
  • Per our database at Business Quant, Dna X's Enterprise Value skyrocketed by 8188.22% in 2021 and then plummeted by 16326.86% in 2022.
  • Over the past 5 years, Dna X's Enterprise Value (Quarter) stood at -$12.3 million in 2021, then decreased by 7.65% to -$13.2 million in 2022, then rose by 27.39% to -$9.6 million in 2023, then increased by 16.2% to -$8.0 million in 2024, then surged by 46.23% to -$4.3 million in 2025.
  • Its Enterprise Value stands at -$4.3 million for Q3 2025, versus -$5.4 million for Q2 2025 and -$4.9 million for Q1 2025.